Materials and methods:
We conducted a retrospective descriptive and analytical study of 45 patients who were registered in the gynecology-obstetrics department at HMIMV between April 1, 2020, and August 1, 2022. These pregnant patients were managed for COVID-19 pneumonia confirmed by real-time polymerase chain reaction (RT-PCR). The data to be analyzed were recorded on a data sheet, and we identified 45 files that met our inclusion criteria. For some patients, we made telephone calls to obtain the remaining information.
The inclusion criteria for our study were pregnant patients who had been diagnosed with COVID-19 infection confirmed by RT-PCR on nasopharyngeal swab samples and were hospitalized in the gynecology-obstetrics and intensive care unit at HMIMV. We only included cases that met these criteria in our evaluation form, which was filled in for each case while ensuring anonymity and encryption of the data.
Our exclusion criteria were non-pregnant patients and pneumonia cases with COVID-19 cause not confirmed by RT-PCR test. After collecting all data, we processed it using SPSS software and analyzed it using headcounts and percentages. This allowed us to draw meaningful conclusions from the data and better understand the impact of COVID-19 on pregnant patients